Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cushing Syndrome × relacorilant × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Pituitary ACTH Hypersecretion 1 Hypertension 1 Diabetes Mellitus, Type 2 1 Cushing Syndrome 1 Carcinoma, Pancreatic Ductal 1 Adrenocortical Carcinoma 1 Adrenal Cortex Neoplasms 1 Adenocarcinoma 1 ACTH Syndrome, Ectopic 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03604198 2026-02-19

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

Corcept Therapeutics

Phase 2 Active not recruiting

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Adrenocortical Carcinoma, Pituitary ACTH Hypersecretion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡